Globe Newswire
CALGARY, Alberta, May 09, 2024 (GLOBE NEWSWIRE) -- Canacol Energy Ltd. (“Canacol” or the “Corporation”) (TSX:CNE; OTCQX:CNNEF; BVC: CNEC) is pleased to report its financial and operating results for the three months ended March 31, 2024. Dollar amounts are expressed in United States dollars, with the exception of Canadian dollar unit prices (“C$”) where indicated and otherwise noted.
Highlights for the three months ended March 31, 2024
- Adjusted... (continue reading...)
Mammoth Lakes, Calif., May 09, 2024 (GLOBE NEWSWIRE) -- Mammoth Lakes is gearing up for another beautiful summer season. As the spring runoff begins in earnest and the winter snow melts away, visitors can expect surging waterfalls, brimming lakes, and a vibrant landscape of wildflowers on full display.
Summer air service into the Eastern Sierra returns with options from Southern California and Northern California. Once you’re on the ground, there are an infinite... (continue reading...)
AURORA, Ontario, May 09, 2024 (GLOBE NEWSWIRE) -- Magna International Inc. (TSX: MG; NYSE: MGA) today announced voting results from its 2024 annual meeting of shareholders held on May 9, 2024. A total of 230,328,916 Common Shares or 80.18% of our issued and outstanding Common Shares were represented in person or by proxy at the meeting. Shareholders voted in favour of each item of business, as follows:
a. Election of Directors
NomineeVotes FORNomineeVotes FORMary... (continue reading...)ISELIN, N.J., May 09, 2024 (GLOBE NEWSWIRE) -- Provident Financial Services, Inc. (NYSE: PFS) (the “Company”), the holding company for Provident Bank (the “Bank”), today announced the pricing of its offering of $225 million of its 9.00% fixed-to-floating rate subordinated notes due 2034 (the “Notes”) in a registered public offering (the “Offering”). The Notes will initially bear interest at 9.00% per annum, with interest payable semiannually in... (continue reading...)
30 month median overall survival (OS); median OS independent of patient CPS score
ORR 34% (CPS≥1); 48% (CPS≥20)
Phase 3 registrational trial planned to initiate in 2024
PRINCETON, N.J., May 09, 2024 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (Nasdaq: PDSB) (“PDS Biotech” or the “Company”), a late-stage immunotherapy company focused on transforming how the immune system targets and kills cancers and the development of infectious disease vaccines,... (continue reading...)
More Globe Newswire
View Older Stories-
Victoria’s Secret & Co. Provides First Quarter 2024 Preliminary Results
-
Kirby McInerney LLP Announces Investigation of Shareholder Claims Against DoubleVerify Inc. (DV)
-
Source Energy Services Reports Q1 2024 Results
-
VitalHub Corp. Reports First Quarter 2024 Financial Results
-
NeOnc Technologies Invited to Present at California Investment Forum in Anaheim on May 10
-
Intermap Announces 42% Revenue Growth in the First Quarter
-
NASCAR Champion’s Luxury Estate, Home to Miss. North Carolina, Enters Market for $6 Million
-
Xtribe, Technology-driven Geolocation-based Commerce Platform, to Go Public on Nasdaq through Proposed Business Combination with WinVest Acquisition Corp. (NASDAQ: WINV)
-
Phio Pharmaceuticals Reports Q1 2024 Results and Provides Business Update
-
ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Sonder Holdings Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm – SOND
-
CTS Corporation Declares a Dividend
-
Hammond Power Solutions Inc. Announces Voting Results of Annual General Meeting
-
Mayfair Gold Files Management Information Circular and Issues Letter to Shareholders
-
Koss Corporation Releases Third Quarter Results
-
Savaria Announces the Voting Results from Annual General and Special Meeting of Shareholders
-
Rogers Sugar Inc. Declares Dividend to Shareholders
-
Strong Performance in Both Business Segments Drives Record Second Quarter Profitability at Rogers Sugar
-
ECN Capital Reports US $0.00 in Adjusted Net Income per Common Share in Q1-2024 Triad results significantly improved and ECN ahead of quarterly guidance
-
Kinross announces Annual Shareholder Meeting voting results
-
Parex Resources Announces Voting Results of Shareholders’ Meeting
-
Associated Capital Group, Inc. Reports Increased First Quarter Book Value
-
Interfor Reports Q1’24 Results
-
Total Energy Services Inc. Announces Q1 2024 Results
-
Inventronics Announces 2024 Q1 Financial Results
-
Diversified Royalty Corp. Announces First Quarter 2024 Results
-
Nova Leap Health Corp. Posts Q1 2024 Results
-
Legacy Housing Corporation Reports First Quarter 2024 Financial Results
-
Osisko Development Provides Corporate Updates
-
Quipt Home Medical Corp. Announces Filing of Final Base Shelf Prospectus
-
Osisko Announces the Voting Results From Its Annual Meeting of Shareholders
-
SeaChange Completes Sale of Substantially All of its Assets to Enghouse
-
Tarsus to Participate in Fireside Chat at the 2024 Bank of America Healthcare Conference
-
BankFinancial Corporation Reports Financial Results for the First Quarter 2024
-
Baltic Horizon Fund Consolidated Unaudited Results for Q1 2024
-
vTv Therapeutics Announces 2024 First Quarter Financial Results and Provides Corporate Update
-
23andMe to Report Q4 and Full Year FY2024 Financial Results
-
Innospec Reports First Quarter 2024 Financial Results
-
Arvinas Announces Upcoming Vepdegestrant Poster Presentations at the 2024 European Society for Medical Oncology (ESMO) Breast Cancer Annual Congress
-
Mawson Infrastructure Group Announces Hiring of Head of Corporate Strategy and Head of Corporate Development
-
Runway Growth Finance Corp. Announces Secondary Offering of Common Stock by Selling Stockholder
-
Planet 13 Announces Q1 2024 Financial Results
-
Orezone Announces Planned Board Succession and New Board Nominee
-
Silver Spike Investment Corp. Reports First Quarter 2024 Financial Results and Announces Cash Dividend of $0.25 Per Share
-
Travere Therapeutics to Present at National Kidney Foundation Spring Clinical Meetings and the 61st European Renal Association Congress
-
Mercer International Inc. Reports First Quarter 2024 Results and Announces Quarterly Cash Dividend Of $0.075
-
Theratechnologies Reports on its Annual Meeting of Shareholders
-
BioSyent Schedules Q1 2024 Earnings Release for May 16, 2024
-
U.S. Energy Corp. Reports Financial and Operating Results for First Quarter 2024
-
Quisitive Sets First Quarter 2024 Earnings Call for Wednesday, May 22, 2024 at 5:00 p.m. ET
-
Conifex Announces First Quarter 2024 Results